ArticleHaematologica2017

Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia.

Karoline V Gleixner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.